Conversion from Radiologically Isolated Syndrome to Multiple Sclerosis: Single Center Retrospective Study Conversion from RIS to MS
Article Sidebar
Main Article Content
Abstract
Objective: The study aimed to investigate the conversion duration from Radiologically Isolated Syndrome (RIS) to multiple sclerosis (MS) and identify factors associated with an increased risk of progression.
Materials and Methods: The study involved a meticulous review of the medical records of 18 patients diagnosed with RIS, who presented without demyelinating clinic in the first applying. Data on patient demographics, laboratory findings, and clinical outcomes were collected. Those who converted from RIS to MS and their conversion duration were recorded. Patients were categorized into two groups; group 1 who progressed to clinically definite MS, and group 2 who remained asymptomatic without clinical progression. The duration of conversion from RIS to MS was also recorded.
Results: The study population had a mean age of 39.8 ± 11.5 years, with 15 females and 3 males. All male patients belonged to Group 1. Although the ages between the two groups did not significantly differ, it was noteworthy that all RIS patients were female. No significant difference between the two groups was observed in the presence of oligoclonal bands or the IgG index. Additionally, the evaluation of spinal lesions did not reveal a statistically significant disparity. The median conversion duration for patients progressing from RIS to MS was 19.5 (interquartile range: 29.25) months.
Conclusion: The study provides valuable insights into the conversion from RIS to MS. The study did not identify spinal lesions, oligoclonal bands, or age as prominent indicators for predicting RIS conversion to MS. Early identification of RIS patients at higher risk of progression may enable timely intervention and improve long-term outcomes.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2023-07-31
Published 2023-08-02
References
Yamout BI, Alroughani R. Multiple Sclerosis. Semin Neurol. 2018;38(2):212-225.
Ward M, Goldman MD. Epidemiology and Pathophysiology of Multiple Sclerosis. Continuum (Minneap Minn). 2022;28(4):988-1005.
Lebrun-Frénay C, Okuda DT, Siva A, Landes-Chateau C, Azevedo CJ, Mondot L, Carra-Dallière C, Zephir H, Louapre C, Durand-Dubief F, Le Page E, Bensa C, Ruet A, Ciron J, Laplaud DA, Casez O, Mathey G, de Seze J, Zeydan B, Makhani N, … RISC, SFSEP and OFSEP investigators. The radiologically isolated syndrome: revised diagnostic criteria. Brain. 2023. awad073. Advance online publication.
Etemadifar M, Janghorbani M, Koushki MM, Etemadifar F, Esfahani MF. Conversion from radiologically isolated syndrome to multiple sclerosis. Int J Prev Med. 2014 Nov;5(11):1379-1386.
Lebrun-Frénay C, Rollot F, Mondot L, Zephir H, Louapre C, Le Page E, Durand-Dubief F, Labauge P, Bensa C, Thouvenot E, Laplaud D, de Seze J, Ciron J, Bourre B, Cabre P, Casez O, Ruet A, Mathey G, Berger E, Moreau T, … RISC, SFSEP, and OFSEP Investigators. Risk Factors and Time to Clinical Symptoms of Multiple Sclerosis Among Patients With Radiologically Isolated Syndrome. JAMA Netw Open. 2021;4(10):e2128271.
Garg N, Smith TW. An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis. Brain Behav. 2015;5(9):e00362.
Kamińska J, Koper OM, Piechal K, Kemona H. Multiple sclerosis - etiology and diagnostic potential. Postepy Hig Med Dosw (Online). 2017;71(0):551-563.
Sati P, Oh J, Constable RT, et al.; NAIMS Cooperative. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative. Nat Rev Neurol. 2016;12:714-722.
Suthiphosuwan S, Sati P, Guenette M, et al. The central vein sign in radiologically isolated syndrome. AJNR Am J Neuroradiol. 2019;40:776-783. doi:10.3174/ajnr.A6045
Hosseiny M, Newsome SD, Yousem DM. Radiologically Isolated Syndrome: A Review for Neuroradiologists. AJNR Am J Neuroradiol. 2020 Sep;41(9):1542-1549.
Krysko KM, Graves JS, Dobson R, Altintas A, Amato MP, Bernard J, Bonavita S, Bove R, Cavalla P, Clerico M, Corona T, Doshi A, Fragoso Y, Jacobs D, Jokubaitis V, Landi D, Llamosa G, Longbrake EE, Maillart E, Marta M, Midaglia L, Shah S, Tintore M, van der Walt A, Voskuhl R, Wang Y, Zabad RK, Zeydan B, Houtchens M, Hellwig K. Sex effects across the lifespan in women with multiple sclerosis. Ther Adv Neurol Disord. 2020 Jul 1;13:1756286420936166.
Okuda DT, Mowry EM, Cree BA, Crabtree EC, Goodin DS, Waubant E, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology. 2011;76:686-692.